Vivos Therapeutics, Inc.
VVOS
$0.53
-$0.04-7.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.99M | -21.17M | -17.10M | -14.32M | -11.24M |
| Total Depreciation and Amortization | 1.59M | 1.31M | 1.01M | 773.00K | 612.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.02M | 601.00K | 776.00K | 869.00K | 822.00K |
| Change in Net Operating Assets | 4.91M | 4.00M | 925.00K | -1.74M | -4.17M |
| Cash from Operations | -17.48M | -15.26M | -14.39M | -14.42M | -13.97M |
| Capital Expenditure | -2.24M | -2.34M | -975.00K | -1.25M | -539.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5.19M | -5.19M | -5.14M | -5.14M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -7.42M | -7.53M | -6.11M | -6.39M | -539.00K |
| Total Debt Issued | 12.07M | 10.67M | 9.23M | 9.64M | -- |
| Total Debt Repaid | -448.00K | -28.00K | -17.00K | -- | -- |
| Issuance of Common Stock | 14.37M | 8.75M | 9.45M | 10.45M | 15.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.32M | -837.00K | -1.38M | -1.79M | -1.06M |
| Cash from Financing | 24.67M | 18.56M | 17.28M | 18.30M | 14.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -232.00K | -4.23M | -3.22M | -2.50M | -269.00K |